Vanderbilt Comprehensive Multiple Sclerosis Center — Nashville, Tennessee

Vanderbilt Comprehensive Multiple Sclerosis Center is a clinical research site located in Nashville, Tennessee, United States 37215.

Crixeo Health Trust Score: 50/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Comprehensive Multiple Sclerosis Center has participated in 2 clinical trials.

Therapeutic areas: Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.

Sponsors: MedDay Pharmaceuticals SA, Atara Biotherapeutics.

Sponsor Feasibility Report

Trust Score: 50/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Comprehensive Multiple Sclerosis Center?

Vanderbilt Comprehensive Multiple Sclerosis Center has a Crixeo Trust Score of 50/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Comprehensive Multiple Sclerosis Center conducted?

Vanderbilt Comprehensive Multiple Sclerosis Center has 2 clinical trials on record. Their work covers Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.

Is Vanderbilt Comprehensive Multiple Sclerosis Center accredited by Crixeo Health?

Vanderbilt Comprehensive Multiple Sclerosis Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Comprehensive Multiple Sclerosis Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.